Food and Drug Administration News

Date Posted
Article Title
6/27/2013
6/25/2013
FDA Allows Two New Cigarettes to Hit Market

It's first such action since agency was given regulatory control over tobacco in 2009

6/24/2013
Vibativ Approved for Certain Bacterial Pneumonia

Only when other treatments aren't suitable

6/21/2013
6/21/2013
FDA OKs Sale of 'Morning-After' Pill Without Age Limit

Girls of all ages will now have easier access to the emergency contraceptive

6/20/2013
New Test IDs Genotype of Hepatitis C

Helps doctors plan treatment

6/14/2013
New Silicone Breast Implants Approved

MemoryShape OK'd for augmentation in women 22 and older

6/13/2013
Xgeva Approved for Rare, Non-Malignant Tumor

Giant cell tumor of the bone

6/7/2013
FDA Panel Votes to Change Tight Restrictions on Diabetes Drug Avandia

Controversial decision comes after a second look at major data review focused on heart risks

6/3/2013
U.S. Cancer Patients Suffering From Drug Shortages

Survey of oncologists finds frequent treatment delays, changes

6/3/2013
Experimental Drug Shows Benefits Against Melanoma in Early Study

Lambrolizumab activates body's immune system to kill cancerous cells, researchers say

5/29/2013
New Drugs, Diagnostic Approved for Advanced Melanoma

This cancer is leading cause of death from skin disease

5/29/2013
U.S. Imports Scarce Nutrition Drugs for Sick Babies

Ingredients for intravenous feeding in short supply after company closure, FDA says

5/29/2013
Blood-Tracking Device Uses New Technology

Memory chips help prevent release of unwanted products

5/20/2013
Revised Sunscreen Labels Should Help Consumers Make Wiser Choices

New survey finds 1 in 7 products still claim an 'SPF' rating of 50 or higher

5/16/2013
Xofigo Approved for Prostate Cancer

When disease has spread to the bones

5/16/2013
Test Approved to Detect Faulty Lung Cancer Gene

Gene present in 10 percent of NSCLC cases

5/15/2013
Simponi Approved for Ulcerative Colitis

Blocks process that contributes to abnormal inflammation

5/15/2013
FDA: Lower Ambien's Dose to Prevent Drowsy Driving

Blood levels from nighttime dose of sleep aid can remain too high the next morning, agency says

5/15/2013
FDA Approves New Drug to Fight Advanced Prostate Cancer

Xofigo was fast-tracked for approval and is meant for tumors that have spread to the bones

5/10/2013
Breo Ellipta Approved for COPD

Respiratory disease is the third-leading cause of death in U.S.

5/6/2013
FDA Warns Pregnant Women About Migraine Drugs

Medicines containing valproate linked to lower IQs in children, agency says

5/6/2013
FDA Proposes Tougher Warnings for Tanning Beds

But stops short of ban for those younger than 18, as advisory panel had recommended

5/2/2013
Lipsticks, Glosses Contain Toxic Metals: Report

Children should not play with these products, researcher says

5/2/2013
White House to Challenge Ruling on Unlimited Access to 'Morning-After' Pill

Move follows FDA decision that only women 15 or older could get emergency contraceptive without prescription

5/1/2013
Obama Administration to Challenge Judge's Ruling on 'Morning-After' Pill

Move follows FDA ruling that females aged 15 or older could get Plan B drug without a prescription

5/1/2013
Antibiotic Azithromycin Won't Harm Healthy Hearts: Study

Researchers found no increased death risk in those free of cardiovascular disease

5/1/2013
4/30/2013
4/25/2013
Soaring Prices Keep Leukemia Drugs From Patients, Experts Say

$100,000-a-year meds seen as obstacle to treatment

4/22/2013
U.S. Supreme Court Rejects Challenge to New Cigarette Labeling

But ruling from another court could still delay or thwart use of graphic anti-smoking images

4/17/2013
FDA Approves 'Abuse-Deterrent' Label for New Oxycontin

Latest formulation is tougher to crush and dissolve, making illicit use more difficult

4/15/2013
FDA Warns Against Sale of Sports Supplements in U.S.

Dangerous stimulant DMAA is sold under variety of ingredient names, agency says

4/10/2013
Drug Company Reps Don't Tell Docs Enough About Side Effects: Survey

Many U.S., Canadian and French physicians prescribed the promoted meds anyway

4/9/2013
Diclegis Approved for Morning Sickness

Among pregnant women who haven't responded to other treatments

4/9/2013
FDA Allows Return of Drug for Morning Sickness

Safety issues resolved, experts say Diclegis' return is long overdue

4/5/2013
Judge: Make Morning-After Pill Available to All Females

Until now, girls 16 and younger needed a prescription for the emergency contraception

4/1/2013
FDA Gives Nod to Longer Use of Nicotine Patch, Gum

Little danger of addiction or abuse seen after years on the market

4/1/2013
New Drug Approved for Type 2 Diabetes

Invokana blocks reabsorption of glucose by the kidneys

3/29/2013
FDA Approves 1st in New Class of Type 2 Diabetes Drugs

Invokana works by blocking reabsorption of glucose in body

3/28/2013
3/28/2013
FDA Approves New Multiple Sclerosis Drug

Tecfidera a 'welcome addition' for patients battling the neurological disease, one expert said

3/26/2013
Oral Allergy Treatment May Ease Asthma, Hay Fever, Study Finds

This under-the-tongue alternative to shots is used in Europe, but not approved in U.S.

3/26/2013
Battery-Operated Skin Patch Offers New Option for Migraine Sufferers

FDA recently approved Zecuity patch to treat the painful headaches

3/26/2013
Temporary Tattoos May Leave Permanent Damage

As spring break nears, FDA warns that seemingly harmless lark might blister, scar skin

3/25/2013
Inhaler Approved for Cystic Fibrosis Patients

Antibiotic device treats Pseudomonas aeruginosa lung infections

3/22/2013
FDA Proposes Tighter Regulation of Public Defibrillators

Agency isn't recalling the cardiac-arrest devices, but wants to require pre-market approval

3/21/2013
Dotarem Approved for Nervous System MRIs

Contrast agent helps doctors view brain and spine

3/20/2013
U.S. Abandons Effort to Place Graphic Labeling on Cigarettes

Court challenges to the proposals will not be sent to Supreme Court, Justice Department says

3/14/2013
FDA Wants to Relax Approval Process for Alzheimer's Drugs

Agency points to need for medications that could prevent, slow disease in an aging population